Brawn Biotech

40
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE899B01015
  • NSEID:
  • BSEID: 530207
INR
21.07
-0.43 (-2.0%)
BSENSE

Dec 19

BSE+NSE Vol: 171

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -18.37% vs -25.80% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -15.96% vs -403.91% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -3.51% vs -53.94% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -39.54% vs -43.64% in Mar 2024

Compare Profit and Loss Results of Brawn Biotech
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
13.00
2.00
11.00
550.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
13.00
2.00
11.00
550.00%
Expenditure (Ex Depriciation)
Stock Adjustments
-4.00
0.00
-4.00
0%
Raw Materials Consumed
16.00
1.00
15.00
1,500.00%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
1.00
0.00
1.00
0%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
15.00
2.00
13.00
650.00%
Operating Profit (PBDIT) excl Other Income
-1.00
0.00
-1.00
0%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
-1.00
0.00
-1.00
0%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
-1.00
0.00
-1.00
0%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
-1.00
0.00
-1.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-1.00
0.00
-1.00
0%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
-1.00
0.00
-1.00
0%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
2.00
0.00
2.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-5.68
0.16
-5.84
-3,650.00%
Profit And Loss - Net Sales
Net Sales 13.46 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -18.37% vs -25.80% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -1.77 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -15.96% vs -403.91% in Mar 2024

Profit And Loss - Interest
Interest 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -3.51% vs -53.94% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax -1.74 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -39.54% vs -43.64% in Mar 2024